VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KHS who wrote (19743)	3/14/1999 4:21:00 PM
From: BigKNY3	Read Replies (4) of 23519

KLS, here are 5 of the studies supported by VVUS that will be presented at the 1999 AUA Annual Meeting during May 1-6: -Gene therapy with K+ channels preserves erectile capacity in the face of diminished neuronal innervation following 12-16 weeks of experimental diabetes in rats (#806 Presented by Dr. George Christ) -The expression of HSLO transcript is largely locally restricted following intracavernous injection (# 807 Presented by Dr. George Christ) -Induction of penile erection by intracavernosal and transurethral administration of zaprinast (a PDE-5 inhibitor) and PGE1 (#848) -Efficacy of MUSE in patients with erectile dysfunction who failed with Viagra Therapy: Results from a multicenter post-marketing study (#813) -Does renewed sexual activity increase cardiac morbidity? Meta-analysis of the experience with MUSE (#823) BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next